ArticleScientific reports2025
Systemic inflammation partially mediates the association between lipid accumulation and osteoarthritis in normal BMI adults.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Obesity-Associated Osteoarthritis: Mechanical-Metabolic Pathogenesis, Obesity Memory and Dual-Target Therapy.Current obesity reports · 2026Review
- New therapeutic target for osteoarthritis: modulating immune-metabolic aberrations and micromilieu remodeling in underlying bone.Frontiers in pharmacology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
This study aims to investigate the association between lipid accumulation product (LAP) levels and osteoarthritis (OA) in participants with normal BMI, and the potential role of the systemic inflammation response index (SIRI) in this association. Participants with normal BMI from the national health and nutrition examination survey (NHANES) database (2009-2018) were included. A weighted multivariable logistic regression was used to analyze the association between LAP levels and OA, and mediation analysis was applied to explore the role of SIRI in this relationship. Among 2408 participants with normal BMI, the average age was 43.85 ± 17.68 years, with 1240 (55%) women, and 210 (8.72%) participants recorded as having OA. Compared with the first quartile, the highest quartile of LAP levels was significantly associated with higher OA prevalence and higher SIRI levels [OA (AOR = 1.969, 95% CI 1.035-3.745, P = 0.039); SIRI (AOR = 1.174, 95% CI 1.029-1.489, P = 0.029)], especially in young women. Compared with the first quartile, the highest quartile of SIRI levels was significantly associated with higher OA prevalence [AOR = 1.542, 95% CI 1.010-2.356, P = 0.045], particularly in young women. The highest quartile of LAP levels was significantly associated with higher OA prevalence, with a portion of the association mediated by SIRI (10.30%), with mediation proportions of 8.92% in younger individuals and 8.69% in women. Even with normal BMI, high LAP levels are significantly associated with a higher prevalence of OA, with part of the association mediated by systemic inflammation, especially in young women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.